A detailed history of Harbour Investments, Inc. transactions in Senti Biosciences, Inc. stock. As of the latest transaction made, Harbour Investments, Inc. holds 15,000 shares of SNTI stock, worth $5,850. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,000
Previous 10,000 50.0%
Holding current value
$5,850
Previous $4,000 125.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 16, 2024

BUY
$0.28 - $0.68 $1,400 - $3,400
5,000 Added 50.0%
15,000 $9,000
Q2 2023

Aug 14, 2023

BUY
$0.6 - $1.14 $4,800 - $9,120
8,000 Added 400.0%
10,000 $6,000
Q4 2022

Feb 15, 2023

BUY
$1.25 - $2.5 $2,500 - $5,000
2,000 New
2,000 $2,000

Others Institutions Holding SNTI

About Senti Biosciences, Inc.


  • Ticker SNTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,757,100
  • Market Cap $17.1M
  • Description
  • Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...
More about SNTI
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.